You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 140 No. 3, March 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bleeding Disorder due to an Isolated Platelet Factor 3 Deficiency

I. Monica Minkoff, MD; Kenneth K. Wu, MD; Joan Walasek; Bernie Lightfoot; Cassandra Smith-McKearn

Arch Intern Med. 1980;140(3):366-367.


Abstract

• To determine the clinical and functional characteristics of isolated platelet factor 3 (PF-3) deficiency, platelet function studies were carried out in 316 patients who were suspected of having a bleeding tendency. Although PF-3 abnormality was observed in 69 patients (22%), an isolated PF-3 abnormality was noted in only three patients. The abnormality was congenital in one patient and secondary to Hashimoto's thyroiditis, Ehlers-Danlos syndrome, and chronic myelocytic leukemia in the other two. Further investigations in the patient with congenital abnormality disclosed that PF-3 activity failed to respond to any of the stimuli tested, and there was a clear dissociation between PF-3 availability and platelet aggregation. The abnormality was due to an intrinsic platelet defect caused by a true deficiency of the membrane phospholipid clotting activity. The findings clearly establish that isolated PF-3 deficiency is an entity of qualitative platelet disorders that may be associated with a severe bleeding tendency.

(Arch Intern Med 140:366-367, 1980)



Author Affiliations

From the Coagulation and Thrombosis Unit, Department of Medicine, Rush Medical College, Rush-Presbyterian-St Luke's Medical Center, Chicago.


Footnotes

Accepted for publication May 18, 1979.

Reprint requests to Coagulation and Thrombosis Unit, Rush-Presbyterian-St Luke's Medical Center, 1753 W Congress Pkwy, Chicago, IL 60612 (Dr Wu).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Haemarthroses after total knee arthroplasty caused by an isolated platelet factor 3 availability defect
Malhotra et al.
J Bone Joint Surg Br 2005;87-B:1549-1552.
ABSTRACT | FULL TEXT  

Procoagulant Expression in Platelets and Defects Leading to Clinical Disorders
Solum
Arterioscler. Thromb. Vasc. Bio. 1999;19:2841-2846.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.